NPO Microgen, a company of the Naimbio holding, is launching on the market the first domestic human normal immunoglobulin for intravenous administration in the...
Pharmaceutical holding Nacimbio of Rostec State Corporation will create new production facilities at NPO Microgen subsidiaries in Ufa, Perm and Tomsk. Biotechnology products, including...
Rostec and the Perm Krai signed a memorandum on co-operation in implementation of two large investment projects. Within the partnership, a new vaccine production...
NPO Microgen (managed by Nacimbio of Rostec State Corporation) announced the registration of bivalent polysaccharide vaccine for the prevention of meningococcal infection by the...